Literature DB >> 29743177

Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development.

L M Ott de Bruin1,2, M Bosticardo3, A Barbieri4, S G Lin5, J H Rowe1, P L Poliani6, K Ching4, D Eriksson7, N Landegren7, O Kämpe7, J P Manis4, L D Notarangelo3.   

Abstract

Hypomorphic RAG1 mutations allowing residual T- and B-cell development have been found in patients presenting with delayed-onset combined immune deficiency with granulomas and/or autoimmunity (CID-G/AI) and abnormalities of the peripheral T- and B-cell repertoire. To examine how hypomorphic Rag1 mutations affect the earliest stages of lymphocyte development, we used CRISPR/Cas9 to generate mouse models with mutations equivalent to those found in patients with CID-G/AI. Immunological characterization showed partial development of T and B lymphocytes, with persistence of naïve cells and preserved serum immunoglobulin but impaired antibody responses and presence of autoantibodies, thereby recapitulating the phenotype seen in patients with CID-G/AI. By using high-throughput sequencing, we identified marked skewing of Igh V and Trb V gene usage in early progenitors, with a bias for productive Igh and Trb rearrangements after selection occurred and increased apoptosis of B-cell progenitors. Rearrangement at the Igk locus was impaired, and polyreactive immunoglobulin M antibodies were detected. This study provides novel insights into how hypomorphic Rag1 mutations alter the primary repertoire of T and B cells, setting the stage for immune dysregulation frequently seen in patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29743177      PMCID: PMC6053949          DOI: 10.1182/blood-2017-12-820985

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

Review 1.  V(D)J recombination: mechanisms of initiation.

Authors:  David G Schatz; Patrick C Swanson
Journal:  Annu Rev Genet       Date:  2011-08-19       Impact factor: 16.830

Review 2.  The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire.

Authors:  Fritz Melchers
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

3.  Characterization of T and B cell repertoire diversity in patients with RAG deficiency.

Authors:  Yu Nee Lee; Francesco Frugoni; Kerry Dobbs; Irit Tirosh; Likun Du; Francesca A Ververs; Heng Ru; Lisa Ott de Bruin; Mehdi Adeli; Jacob H Bleesing; David Buchbinder; Manish J Butte; Caterina Cancrini; Karin Chen; Sharon Choo; Reem A Elfeky; Andrea Finocchi; Ramsay L Fuleihan; Andrew R Gennery; Dalia H El-Ghoneimy; Lauren A Henderson; Waleed Al-Herz; Elham Hossny; Robert P Nelson; Sung-Yun Pai; Niraj C Patel; Shereen M Reda; Pere Soler-Palacin; Raz Somech; Paolo Palma; Hao Wu; Silvia Giliani; Jolan E Walter; Luigi D Notarangelo
Journal:  Sci Immunol       Date:  2016-12-16

Review 4.  Mechanisms of central tolerance for B cells.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2017-04-03       Impact factor: 53.106

5.  Abnormalities of T-cell receptor repertoire in CD4+ regulatory and conventional T cells in patients with RAG mutations: Implications for autoimmunity.

Authors:  Jared H Rowe; Brian D Stadinski; Lauren A Henderson; Lisa Ott de Bruin; Ottavia Delmonte; Yu Nee Lee; M Teresa de la Morena; Rakesh K Goyal; Anthony Hayward; Chiung-Hui Huang; Maria Kanariou; Alejandra King; Taco W Kuijpers; Jian Yi Soh; Benedicte Neven; Jolan E Walter; Eric S Huseby; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2017-08-31       Impact factor: 10.793

6.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model.

Authors:  Khie Khiong; Masaaki Murakami; Chika Kitabayashi; Naoko Ueda; Shin-ichiro Sawa; Akemi Sakamoto; Brian L Kotzin; Stephen J Rozzo; Katsuhiko Ishihara; Marileila Verella-Garcia; John Kappler; Philippa Marrack; Toshio Hirano
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency.

Authors:  Jolan E Walter; Francesca Rucci; Laura Patrizi; Mike Recher; Stephan Regenass; Tiziana Paganini; Marton Keszei; Itai Pessach; Philipp A Lang; Pietro Luigi Poliani; Silvia Giliani; Waleed Al-Herz; Morton J Cowan; Jennifer M Puck; Jack Bleesing; Tim Niehues; Catharina Schuetz; Harry Malech; Suk See DeRavin; Fabio Facchetti; Andrew R Gennery; Emma Andersson; Naynesh R Kamani; JoAnn Sekiguchi; Hamid M Alenezi; Javier Chinen; Ghassan Dbaibo; Gehad ElGhazali; Adriano Fontana; Srdjan Pasic; Cynthia Detre; Cox Terhorst; Frederick W Alt; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

8.  Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity.

Authors:  Lauren A Henderson; Francesco Frugoni; Gregory Hopkins; Helen de Boer; Sung-Yun Pai; Yu Nee Lee; Jolan E Walter; Melissa M Hazen; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-07-24       Impact factor: 10.793

Review 9.  Mechanics of T cell receptor gene rearrangement.

Authors:  Michael S Krangel
Journal:  Curr Opin Immunol       Date:  2009-04-09       Impact factor: 7.486

10.  Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.

Authors:  Hanna IJspeert; Gertjan J Driessen; Michael J Moorhouse; Nico G Hartwig; Beata Wolska-Kusnierz; Krzysztof Kalwak; Anna Pituch-Noworolska; Irina Kondratenko; Joris M van Montfrans; Ester Mejstrikova; Arjan C Lankester; Anton W Langerak; Dik C van Gent; Andrew P Stubbs; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Allergy Clin Immunol       Date:  2014-01-11       Impact factor: 10.793

View more
  13 in total

Review 1.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 2.  RAG Deficiency: Two Genes, Many Diseases.

Authors:  Ottavia M Delmonte; Catharina Schuetz; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2018-07-25       Impact factor: 8.317

Review 3.  Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.

Authors:  Ottavia M Delmonte; Anna Villa; Luigi D Notarangelo
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

Review 4.  RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.

Authors:  Marita Bosticardo; Francesca Pala; Luigi D Notarangelo
Journal:  Eur J Immunol       Date:  2021-03-22       Impact factor: 6.688

Review 5.  Recent advances in understanding RAG deficiencies.

Authors:  Andrew Gennery
Journal:  F1000Res       Date:  2019-02-04

6.  Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID.

Authors:  Laura Garcia-Perez; Marja van Eggermond; Lieke van Roon; Sandra A Vloemans; Martijn Cordes; Axel Schambach; Michael Rothe; Dagmar Berghuis; Chantal Lagresle-Peyrou; Marina Cavazzana; Fang Zhang; Adrian J Thrasher; Daniela Salvatori; Pauline Meij; Anna Villa; Jacques J M Van Dongen; Jaap-Jan Zwaginga; Mirjam van der Burg; H Bobby Gaspar; Arjan Lankester; Frank J T Staal; Karin Pike-Overzet
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-31       Impact factor: 6.698

7.  A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.

Authors:  Steven Strubbe; Marieke De Bruyne; Ulrich Pannicke; Elien Beyls; Bart Vandekerckhove; Georges Leclercq; Elfride De Baere; Victoria Bordon; Anne Vral; Klaus Schwarz; Filomeen Haerynck; Tom Taghon
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 8.  Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side.

Authors:  Laura Garcia-Perez; Anita Ordas; Kirsten Canté-Barrett; Pauline Meij; Karin Pike-Overzet; Arjan Lankester; Frank J T Staal
Journal:  Pharmaceutics       Date:  2020-06-13       Impact factor: 6.321

9.  CD3ε+ Cells in Pigs With Severe Combined Immunodeficiency Due to Defects in ARTEMIS.

Authors:  Adeline N Boettcher; A Giselle Cino-Ozuna; Yash Solanki; Jayne E Wiarda; Ellie Putz; Jeana L Owens; Sara A Crane; Amanda P Ahrens; Crystal L Loving; Joan E Cunnick; Raymond R R Rowland; Sara E Charley; Jack C M Dekkers; Christopher K Tuggle
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

10.  Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.

Authors:  Christoph B Geier; Jocelyn R Farmer; Zsofia Foldvari; Boglarka Ujhazi; Jolanda Steininger; John W Sleasman; Suhag Parikh; Meredith A Dilley; Sung-Yun Pai; Lauren Henderson; Melissa Hazen; Benedicte Neven; Despina Moshous; Svetlana O Sharapova; Snezhina Mihailova; Petya Yankova; Elisaveta Naumova; Seza Özen; Kevin Byram; James Fernandez; Hermann M Wolf; Martha M Eibl; Luigi D Notarangelo; Leonard H Calabrese; Jolan E Walter
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.